FDA
-
-
-
-
-
-
-
Bellicum Pharma (BLCM) Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
-
-
-
-
-
-
-
Bellicum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
After-Hours Movers 04/11: (QNST) (BLCM) (RETA) Higher; (BBBY) (NVAX) (COOL) Lower (more...)
-
-
-
-
-
-
-
Bellicum Announces Update on Clinical Hold of U.S. BPX-501 Studies
-
-
-
-
-
-
-
Bellicum Reports Third Quarter 2017 Financial Results
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

